Episode 38
Treatment of Acinetobacter spp. Infections (AAC ed.)
Editors in Conversation · Cesar Arias, Yohei Doi, Joseph Patrick Hornak
December 11, 202143m 50s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Infections caused by carbapenem-resistant Acinetobacter spp. are considered an urgent public health problem. Antibiotic options are scarce but new drugs may be available in the near future. We discuss this important topic with experts in the field.
Topics discussed:- Acinetobacter as an opportunistic pathogen
- Therapeutic approaches for Acinetobacter infections
- The future approach for this MDR organisms.
- Dr. Yohei Doi, Professor and Director, Center for Innovative Antimicrobial Therapy, University of Pittsburgh Medical Center, Pittsburgh, PA
- Dr. Joseph Patrick Hornak. Fellow, Infectious Diseases, University of Texas Medical Branch, Galveston, TX